logo

For the first time, Storebjerg et al. [1] describe the prevalence of the HOXB13 G84E mutation in a Danish population and its association with prostate cancer risk and features indi[...]
Introduction In the last few years there have been concerted attempts at using the power of the immune system as an effective treatment option for cancer. This has become possible [...]
In a study in this issue of BJUI, Aghazadeh et al. [1] were able to show that there was a significant relationship between simulated robotic performance and robotic clinical perfor[...]
One of the great triumphs in Urology is the transition of prostate cancer surgery from a universally morbid operation to one that now focuses on postoperative quality of life. This[...]
The ‘Guideline of guidelines: thromboprophylaxis for urological surgery’, published in this month’s issue of BJUI by Violette et al. [1], addresses a critical issue in urolog[...]
The wide dissemination of prostate cancer screening has increased the number of men diagnosed with low-risk, indolent cancers that are better managed with active surveillance (AS) [...]
Robot-assisted surgery is increasing and patient selection is important to ensure mitigation of risk, patient safety and allow for the surgeon’s training curve. This is espec[...]
Prostate cancer is the most commonly diagnosed solid organ tumour and the second leading cause of cancer death in men in the USA. The exact path of these tumours from inception to [...]
It has been a nice summer for the BJUI. Our impact factor has gone up to 4.387, the highest ever in the history of the Journal and we made the Altmetrics Top 50 for the first time [...]